Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia
Objective: Investigating D-Dimer/D-Di and plasminogen activator inhibitor type-1/PAI-1 levels throughout gestation in women with preeclampsia/PE risk factors. Methods: D-Di and PAI-1 plasma levels were determined in 28 women at 12-19, 20-29, 30-34 and 35-40 weeks of gestation. Results: D-Di was lowe...
Saved in:
Main Authors: | Flávia Campos Lucena (Author), Eura Martins Lage (Author), Patrícia Gonçalves Teixeira (Author), Alexandre Simões Barbosa (Author), Rejane Diniz (Author), Bashir Lwaleed (Author), André Talvani (Author), Patrícia Nessralla Alpoim (Author), Luiza Oliveira Perucci (Author), Luci Maria SantAna Dusse (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are Endocan Plasma Levels Altered in Preeclampsia?
by: Ana Cristina dos Santos Lopes, et al.
Published: (2021) -
Avaliação do dímero D (D-Di) na doença hipertensiva específica da gravidez (DHEG) D-dimer plasma levels assessment in preeclampsia
by: Luci Maria Sant'Ana Dusse, et al.
Published: (2003) -
Complete blood count as a biomarker for preeclampsia with severe features diagnosis: a machine learning approach
by: Daniella Castro Araújo, et al.
Published: (2024) -
Early and late-onset preeclampsia: effects of DDAH2 polymorphisms on ADMA levels and association with DDAH2 haplotypes
by: Fernanda Santos Mendes, et al.
Published: (2024) -
Fresh frozen plasma as a source of plasminogen for ligneous conjunctivitis: Case report and a review of the literature
by: Benjamin J Park, et al.
Published: (2021)